Is Metformin Hydrochloride the same as Pioglitazone And Metformin Hydrochloride?

No. Metformin Hydrochloride (Metformin Hydrochloride Extended-Release Tablets) and Pioglitazone And Metformin Hydrochloride (Pioglitazone And Metformin Hydrochloride) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Which has fewer side effects, Metformin Hydrochloride Extended-Release Tablets or Pioglitazone And Metformin Hydrochloride?

Side-effect frequency varies by individual. The side-effect comparison section on this page shows FAERS-reported events for each drug side by side. FAERS is voluntary reporting, so it reflects what patients and clinicians chose to report, not absolute population risk.

Can I switch from Metformin Hydrochloride Extended-Release Tablets to Pioglitazone And Metformin Hydrochloride?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

Metformin Hydrochloride Extended-Release Tablets vs Pioglitazone And Metformin Hydrochloride

Compare Metformin Hydrochloride Extended-Release Tablets (Metformin Hydrochloride) and Pioglitazone And Metformin Hydrochloride (Biguanide), clinical data, side effects, and patient experiences.

Metformin Hydrochloride Extended-Release Tablets

Metformin Hydrochloride · Biguanide

How it works

Other agent

Approved for

See full prescribing information

OralTablet

Pioglitazone And Metformin Hydrochloride

· Biguanide

How it works

12.1 Mechanism of Action ACTOPLUS MET combines two antihyperglycemic agents: pioglitazone and metformin. Pioglitazone Pioglitazone is a thiazolidinedione that depends on the presen...

Approved for

a thiazolidinedione agonist of peroxisome proliferator receptor gamma

and metformin hydrochloride (HCl)

a biguanide

OralTablet

Quick Comparison

Metformin Hydrochloride Extended-Release TabletsPioglitazone And Metformin Hydrochloride

Drug Class

Biguanide

Route

Oral

Half-Life

N/A

FDA Approved

N/A

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

Metformin Hydrochloride Extended-Release Tablets

Nausea

>10%

Diarrhea

1-10%

Drug Not Working

1-10%

Fatigue

1-10%

Vomiting

1-10%

Weight Loss

1-10%

Shortness of Breath

1-10%

Dizziness

1-10%

Pioglitazone And Metformin Hydrochloride

Nausea

1-10%

Weight Loss

1-10%

Diarrhea

1-10%

Drug Not Working

0.1-1%

Fatigue

0.1-1%

Shortness of Breath

0.1-1%

Vomiting

0.1-1%

Dizziness

0.1-1%

FDA Warnings

Metformin Hydrochloride Extended-Release Tablets

5 WARNINGS AND PRECAUTIONS Lactic Acidosis : See boxed warning
2 ) Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues : Increased risk of hypoglycemia when used in combination with insulin and/or an insulin secretagogue
1 Lactic Acidosis There have been postmarketing cases of metformin-associated lactic acidosis, including fatal cases
Metformin decreases liver uptake of lactate increasing lactate blood levels which may increase the risk of lactic acidosis, especially in patients at risk

Pioglitazone And Metformin Hydrochloride

5 WARNINGS AND PRECAUTIONS Congestive heart failure: Fluid retention may occur and can exacerbate or lead to congestive heart failure
Combination use with insulin and use in congestive heart failure NYHA Class I and II may increase risk
3 ) Hypoglycemia: Consider a lower dose of insulin or insulin secretagogue to reduce risk of hypoglycemia when used in combination with ACTOPLUS MET
4 ) Hepatic effects: Postmarketing reports of hepatic failure, sometimes fatal

Clinical Trial Data

No head-to-head clinical studies found for Metformin Hydrochloride Extended-Release Tablets vs Pioglitazone And Metformin Hydrochloride.

Metformin Hydrochloride Extended-Release Tablets vs Pioglitazone And Metformin Hydrochloride: What You Should Know

Key Differences

Both Metformin Hydrochloride Extended-Release Tablets and Pioglitazone And Metformin Hydrochloride belong to the Biguanide class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

Metformin Hydrochloride Extended-Release Tablets carries 4 FDA warnings. Pioglitazone And Metformin Hydrochloride carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

Metformin vs Metformin Hydrochloride Extended-Release Tablets→Metformin vs Pioglitazone And Metformin Hydrochloride→Metformin Er 500 Mg vs Metformin Hydrochloride Extended-Release Tablets→Metformin Er 500 Mg vs Pioglitazone And Metformin Hydrochloride→Metformin Hcl vs Metformin Hydrochloride Extended-Release Tablets→Metformin Hcl vs Pioglitazone And Metformin Hydrochloride→

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

Metformin Hydrochloride Extended-Release Tablets: DailyMed label · FAERS adverse events · ClinicalTrials.gov
Pioglitazone And Metformin Hydrochloride: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

Metformin Hydrochloride Extended-Release Tablets vs Pioglitazone And Metformin Hydrochloride

Compare Metformin Hydrochloride Extended-Release Tablets (Metformin Hydrochloride) and Pioglitazone And Metformin Hydrochloride (Biguanide), clinical data, side effects, and patient experiences.

Metformin Hydrochloride Extended-Release Tablets

Metformin Hydrochloride · Biguanide

How it works

Other agent

Approved for

See full prescribing information

OralTablet

Pioglitazone And Metformin Hydrochloride

· Biguanide

How it works

12.1 Mechanism of Action ACTOPLUS MET combines two antihyperglycemic agents: pioglitazone and metformin. Pioglitazone Pioglitazone is a thiazolidinedione that depends on the presen...

Approved for

a thiazolidinedione agonist of peroxisome proliferator receptor gamma

and metformin hydrochloride (HCl)

a biguanide

OralTablet

Quick Comparison

Metformin Hydrochloride Extended-Release TabletsPioglitazone And Metformin Hydrochloride

Drug Class

Biguanide

Route

Oral

Half-Life

N/A

FDA Approved

N/A

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

Metformin Hydrochloride Extended-Release Tablets

Nausea

>10%

Diarrhea

1-10%

Drug Not Working

1-10%

Fatigue

1-10%

Vomiting

1-10%

Weight Loss

1-10%

Shortness of Breath

1-10%

Dizziness

1-10%

Pioglitazone And Metformin Hydrochloride

Nausea

1-10%

Weight Loss

1-10%

Diarrhea

1-10%

Drug Not Working

0.1-1%

Fatigue

0.1-1%

Shortness of Breath

0.1-1%

Vomiting

0.1-1%

Dizziness

0.1-1%

FDA Warnings

Metformin Hydrochloride Extended-Release Tablets

5 WARNINGS AND PRECAUTIONS Lactic Acidosis : See boxed warning
2 ) Hypoglycemia with Concomitant Use with Insulin and Insulin Secretagogues : Increased risk of hypoglycemia when used in combination with insulin and/or an insulin secretagogue
1 Lactic Acidosis There have been postmarketing cases of metformin-associated lactic acidosis, including fatal cases
Metformin decreases liver uptake of lactate increasing lactate blood levels which may increase the risk of lactic acidosis, especially in patients at risk

Pioglitazone And Metformin Hydrochloride

5 WARNINGS AND PRECAUTIONS Congestive heart failure: Fluid retention may occur and can exacerbate or lead to congestive heart failure
Combination use with insulin and use in congestive heart failure NYHA Class I and II may increase risk
3 ) Hypoglycemia: Consider a lower dose of insulin or insulin secretagogue to reduce risk of hypoglycemia when used in combination with ACTOPLUS MET
4 ) Hepatic effects: Postmarketing reports of hepatic failure, sometimes fatal

Clinical Trial Data

No head-to-head clinical studies found for Metformin Hydrochloride Extended-Release Tablets vs Pioglitazone And Metformin Hydrochloride.

Metformin Hydrochloride Extended-Release Tablets vs Pioglitazone And Metformin Hydrochloride: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

Metformin Hydrochloride Extended-Release Tablets: DailyMed label · FAERS adverse events · ClinicalTrials.gov
Pioglitazone And Metformin Hydrochloride: DailyMed label · FAERS adverse events · ClinicalTrials.gov